Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$36.08 - $54.3 $15,334 - $23,077
-425 Reduced 80.04%
106 $3,000
Q4 2023

Feb 13, 2024

BUY
$34.32 - $57.55 $13,933 - $23,365
406 Added 324.8%
531 $29,000
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $6,268 - $7,222
-123 Reduced 49.6%
125 $6,000
Q1 2023

May 12, 2023

SELL
$35.33 - $55.79 $18,760 - $29,624
-531 Reduced 68.16%
248 $13,000
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $19,007 - $32,172
779 New
779 $28,000
Q1 2021

Apr 26, 2021

SELL
$140.25 - $196.86 $1.03 Million - $1.45 Million
-7,373 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$126.47 - $163.7 $932,463 - $1.21 Million
7,373 New
7,373 $1.04 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.